Reagents News and Research

RSS

Avacta partners with Cytiva to develop a rapid test for COVID-19

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences.

From Avacta Life Sciences Ltd. 9 Apr 2020

PCR Biosystems continues to scale up production to ensure uninterrupted supply of COVID-19 test reagents

PCR Biosystems, the UK-based PCR experts, are continuing to scale up operations to ensure the critical enzyme mix for COVID-19 tests remain available to the UK and global healthcare systems as demand for testing rises.

9 Apr 2020

New method for digital tissue diagnostics can streamline diagnosis and improve accuracy

The Swedish MedTech company Lumito is at its final stages of developing a new and unique method for digital tissue diagnostics that streamlines diagnosis and improves accuracy.

9 Apr 2020

Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel

Promega Corporation’s GoTaq Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use.

From Promega Corporation 6 Apr 2020

Francis Crick Institute and UCLH play vital role in national COVID-19 testing effort

NHS staff testing for COVID-19 has been boosted by repurposing the Francis Crick Institute’s laboratory facilities as a testing facility, to help combat the spread of infection and allow key workers to perform lifesaving duties and remain safe.

3 Apr 2020

OXGENE and The Native Antigen Company Announce Collaboration to Increase COVID-19 Antigen Production for Diagnostic Kits and Vaccine Development

OXGENE™ and The Native Antigen Company today announced a collaboration to scale up production of SARS-CoV-2 (COVID-19) reagents.

2 Apr 2020

New Vivalytic Viral Respiratory Tract Infection Array can identify SARS-CoV-2 virus

A game-changing point of care coronavirus test from global diagnostics company Randox Laboratories and leading technology manufacturer Bosch Healthcare Solutions will launch in April 2020.

From Randox Laboratories Ltd. 1 Apr 2020

Researchers develop new PCR system for detection of SARS-CoV-2 virus

Michael Traugott and the spin-off company Sinsoma GmbH, together with the Departments of Zoology and Microbiology at the University of Innsbruck, are developing a new PCR system for the detection of the SARS-CoV-2 virus.

1 Apr 2020

'Pool testing' for COVID-19 may help increase testing capacities across the globe

Now, a team of researchers at the German Red Cross Blood Donor Service and the Institute for Medical Virology at the University Hospital Frankfurt at Goethe University have developed a pool testing procedure that will make it possible to rapidly increase worldwide testing capacities for SARS-CoV-2.

1 Apr 2020

CELLINK receives healthcare consumables order of SEK 5,200,000

CELLINK AB (publ) has received an order for consumables for healthcare through an order from the National Board of Health and Welfare in Sweden, the order value is a total of 5,200,000 SEK.

From CELLINK 31 Mar 2020

Researchers find new strategy for developing tissue regeneration scaffolds

In Japan, an increase in the aging population has exacerbated the demand for regenerative medicine to address increasingly common diseases, such as knee osteoarthritis.

31 Mar 2020

INTEGRA, BioTools and Sullivan Nicolaides Pathology work together to accelerate COVID-19 testing

The global COVID-19 pandemic has placed unprecedented demands on pathology services to test patient samples for the novel SARS-CoV-2 coronavirus alongside their pre-existing respiratory virus panels.

From INTEGRA Biosciences 31 Mar 2020

Gene therapy investigators can greatly benefit from National Gene Vector Biorepository

Gene therapy investigators can greatly benefit from the resources and services provided by the National Gene Vector Biorepository, housed at the Indiana University School of Medicine.

27 Mar 2020

Russian researchers explain why new pathogenic viruses are so hard to detect

In a recently published fundamental review dedicated to the diagnostics of viral infections, a Russian research team featuring MIPT researchers was the first to systematically describe and summarize the cutting-edge technologies in the rapidly developing field of genetics.

25 Mar 2020

HORIBA Medical’s Yumizen G200 hemostasis device validated for use with UK NEQAS BC samples

HORIBA UK Ltd, Medical announces that a study has shown that UK National External Quality Assessment Scheme for Blood Coagulation external quality assessment lyophilized plasma samples can be tested on its Yumizen G200 hemostasis instrument.

From HORIBA Medical 20 Mar 2020

India gives Roche Diagnostics the license to conduct coronavirus tests, looks to delay disease progression

Following the news that the Drug Controller General of India has given license to Roche Diagnostics India to conduct coronavirus tests, Rohit Anand, Medical Devices Analyst at GlobalData, a leading data and analytics company, offers his view.

From Roche Sequencing and Life Science 20 Mar 2020

Gyrolab technology to be incorporated into Jefferson Institute for Bioprocessing specialized teaching curriculum and training programs

Gyros Protein Technologies and JIB announced that Gyrolab xPlore™ immunoassay system from Gyros Protein Technologies will be integrated into JIB’s curriculum.

From Gyros Protein Technologies AB 17 Mar 2020

Testing shortages force extreme shift in strategy by local health officials

Public health officials in California's state capital region announced this week they have stopped tracing the contacts of patients diagnosed with the novel coronavirus. They've also ceased recommending quarantines for residents exposed to people confirmed to have the virus.

13 Mar 2020

Single-drug therapy can attack several cellular targets using different modes of action

Clinicians combat the drug resistances of some cancer types by using a combination of different drugs. To make this approach more effective, chemists have designed a chemical conjugate that can simultaneously attack several cellular targets using different modes of action.